TrialStem cells translational medicine2012

Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.

Violaine K Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.